Table 3.
All Cases | 1-Year | 2-Year | 3-Year | 4-Year | 5-Year | 6-Year | 7-Year | Total Value |
WFA+-M2BP | 0.59942 | 0.63898 | 0.72643 | 0.71793 | 0.73864 | 0.74045 | 0.77041 | 4.93226 |
APRI | 0.59556 | 0.53636 | 0.51389 | 0.51932 | 0.53050 | 0.52431 | 0.54490 | 3.76484 |
FIB-4 index | 0.53427 | 0.55076 | 0.64085 | 0.64111 | 0.65829 | 0.65625 | 0.62857 | 4.31010 |
Platelet count | 0.62403 | 0.53415 | 0.51403 | 0.53104 | 0.54725 | 0.57610 | 0.55306 | 3.87966 |
Hyaluronic acid | 0.6793 | 0.69324 | 0.73218 | 0.67026 | 0.68162 | 0.67448 | 0.61888 | 4.74996 |
HCC Cases | 1-Year | 2-Year | 3-Year | 4-Year | 5-Year | 6-Year | 7-Year | Total Value |
WFA+-M2BP | 0.52695 | 0.51717 | 0.61068 | 0.58456 | 0.53604 | 0.64912 | 0.51282 | 3.93734 |
APRI | 0.56469 | 0.50166 | 0.54505 | 0.53309 | 0.56757 | 0.61404 | 0.50000 | 3.82610 |
FIB-4 index | 0.58356 | 0.50388 | 0.59956 | 0.59743 | 0.63514 | 0.68421 | 0.58974 | 4.19352 |
Platelet count | 0.62197 | 0.54928 | 0.50111 | 0.52574 | 0.55856 | 0.52632 | 0.57692 | 3.85990 |
Hyaluronic acid | 0.63005 | 0.66445 | 0.70912 | 0.60478 | 0.45495 | 0.77193 | 0.64103 | 4.47631 |
Non-HCC | 1-Year | 2-Year | 3-Year | 4-Year | 5-Year | 6-Year | 7-Year | Total Value |
WFA+-M2BP | NA | NA | 0.86039 | 0.74122 | 0.77451 | 0.77273 | 0.82778 | 3.97663 |
APRI | NA | NA | 0.70779 | 0.60187 | 0.67507 | 0.64310 | 0.58333 | 3.21116 |
FIB-4 index | NA | NA | 0.80844 | 0.74707 | 0.76751 | 0.75758 | 0.73333 | 3.81393 |
Platelet count | NA | NA | 0.61364 | 0.70141 | 0.66106 | 0.69024 | 0.66667 | 3.33302 |
Hyaluronic acid | NA | NA | 0.83442 | 0.69087 | 0.80952 | 0.74074 | 0.67222 | 3.74777 |
WFA+-M2BP, Wisteria floribunda agglutinin-positive Mac-2-binding protein; APRI, aspartate aminotransferase to platelet ration index; HCC, hepatocellular carcinoma; NA, not available.